Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
Conditions : Breast Cancer; Leptomeningeal Disease Interventions : Biological: cDC1 Vaccine; Drug: Trastuzumab; Drug: Nivolumab Sponsors : H. Lee Moffitt Cancer Center and Research Institute; United…
Read the full article16h agoen

Comments
Sign in to join the conversation.
No comments yet. Be the first.